- Home
- HLMN vs CNTA Comparison
HLMN vs CNTA Comparison
Compare HLMN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLMN
- CNTA
- Stock Information
- Founded
- HLMN 1964
- CNTA 2020
- Country
- HLMN United States
- CNTA United Kingdom
- Employees
- HLMN N/A
- CNTA N/A
- Industry
- HLMN Industrial Machinery/Components
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HLMN Consumer Discretionary
- CNTA Health Care
- Exchange
- HLMN Nasdaq
- CNTA Nasdaq
- Market Cap
- HLMN 2.2B
- CNTA 1.8B
- IPO Year
- HLMN N/A
- CNTA 2021
- Fundamental
- Price
- HLMN $7.75
- CNTA $12.30
- Analyst Decision
- HLMN Buy
- CNTA Strong Buy
- Analyst Count
- HLMN 5
- CNTA 10
- Target Price
- HLMN $11.25
- CNTA $26.11
- AVG Volume (30 Days)
- HLMN 2.1M
- CNTA 617.5K
- Earning Date
- HLMN 04-29-2025
- CNTA 05-20-2025
- Dividend Yield
- HLMN N/A
- CNTA N/A
- EPS Growth
- HLMN N/A
- CNTA N/A
- EPS
- HLMN 0.09
- CNTA N/A
- Revenue
- HLMN $1,481,633,000.00
- CNTA N/A
- Revenue This Year
- HLMN $5.53
- CNTA N/A
- Revenue Next Year
- HLMN $4.44
- CNTA N/A
- P/E Ratio
- HLMN $82.67
- CNTA N/A
- Revenue Growth
- HLMN 0.31
- CNTA N/A
- 52 Week Low
- HLMN $6.64
- CNTA $7.75
- 52 Week High
- HLMN $12.08
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HLMN 50.58
- CNTA 40.97
- Support Level
- HLMN $6.64
- CNTA $11.88
- Resistance Level
- HLMN $7.54
- CNTA $14.39
- Average True Range (ATR)
- HLMN 0.32
- CNTA 0.79
- MACD
- HLMN 0.10
- CNTA -0.00
- Stochastic Oscillator
- HLMN 81.92
- CNTA 18.68
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.